Siddiqi N J, Alhomida A S, Maheshwari R K, Pandey V C
Department of Biochemistry, King Saud University, PO Box 2455, Riyadh 11451, Saudi Arabia.
In Vivo. 2001 Jan-Feb;15(1):77-80.
Plasmodium yoelii nigeriensis (P. y. nigeriensis) produces lethal malaria infection in Swiss albino mice. Reactive oxygen species (ROS) are important mediators of tissue injury during malaria infection.
To study the status of hepatic oxidative stress and antioxidant defense indices during Plasmodium yoelii nigeriensis (P. y. nigeriensis) infection and poly ICLC treatment of normal and P. y. nigeriensis infected Swiss albino mice.
Mice were divided into four groups viz., 1. Normal mice, 2. Normal mice treated with poly ICLC (5 mg/kg body weight, i.p.), 3. P. y. nigeriensis infected mice and 4. P. y. nigeriensis infected mice treated with poly ICLC (5 mg/kg body weight, i.p.).
P. y. nigeriensis infection caused a significant increase in hepatic oxidative stress indices viz., xanthine oxidase and lipid peroxidation. This was accompanied by a significant increase in antioxidant defense indices viz., reduced glutathione (GSH), glutathione reductase while superoxide dismutase and catalase showed a significant decrease with respect to normal mice. Poly ICLC treatment of P. y. nigeriensis infected mice did not cure blood parasitemia. However, poly ICLC treatment of normal and P. y. nigeriensis resulted in an increased generation of hepatic oxidative stress and an associated increase in the antioxidant defense indices.
poly ICLC therapy alone is not sufficient to treat the malaria infection caused by multiple drug resistant strain of P. y. nigeriensis. Therefore there is a need to develop newer antimalarias which can act alone or in combination with traditional antimalarials to be effective against drug resistant malarial parasite.
约氏疟原虫尼日尔亚种(P. y. nigeriensis)可在瑞士白化小鼠中引发致命的疟疾感染。活性氧(ROS)是疟疾感染期间组织损伤的重要介质。
研究约氏疟原虫尼日尔亚种(P. y. nigeriensis)感染以及聚肌胞苷酸(poly ICLC)处理正常和感染P. y. nigeriensis的瑞士白化小鼠期间肝脏氧化应激和抗氧化防御指标的状况。
将小鼠分为四组,即1. 正常小鼠;2. 用聚肌胞苷酸(5毫克/千克体重,腹腔注射)处理的正常小鼠;3. 感染P. y. nigeriensis的小鼠;4. 用聚肌胞苷酸(5毫克/千克体重,腹腔注射)处理的感染P. y. nigeriensis的小鼠。
P. y. nigeriensis感染导致肝脏氧化应激指标(即黄嘌呤氧化酶和脂质过氧化)显著增加。同时,抗氧化防御指标(即还原型谷胱甘肽(GSH)、谷胱甘肽还原酶)也显著增加,而超氧化物歧化酶和过氧化氢酶相对于正常小鼠则显著降低。聚肌胞苷酸处理感染P. y. nigeriensis的小鼠并未治愈血中疟原虫血症。然而,聚肌胞苷酸处理正常和感染P. y. nigeriensis的小鼠会导致肝脏氧化应激增加以及抗氧化防御指标相应增加。
单独使用聚肌胞苷酸疗法不足以治疗由多重耐药的P. y. nigeriensis菌株引起的疟疾感染。因此,需要开发新的抗疟药物,其可单独作用或与传统抗疟药物联合使用,以有效对抗耐药疟原虫。